510(k) K212181
K212181 is an FDA 510(k) premarket notification submitted by Phadia AB for the device "ImmunoCAP Allergen f433, Allergen component rTri a 14 LTP, Wheat, ImmunoCAP Allergen f416, Allergen component rTri a 19 Omega-5 Gliadin, Wheat, ImmunoCAP Allergen f449, Allergen component rSes i 1 Sesame seed". The FDA issued a decision of Substantially Equivalent on August 3, 2022. The device falls under product code DHB (System, Test, Radioallergosorbent (Rast) Immunological), a Class II device regulated under 21 CFR 866.5750. Phadia AB has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- August 3, 2022
- Date Received
- July 13, 2021
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- System, Test, Radioallergosorbent (Rast) Immunological
- Device Class
- Class II
- Regulation Number
- 866.5750
- Review Panel
- IM
- Submission Type